跳至主要内容
临床试验/NCT04951752
NCT04951752Unknown不适用

Effect of the Transmuscular Quadratus Lumborum Block on Duration of Stay in Recovery: a Single-centre, Retrospective, Observational Study Based on Five Selected Randomised Controlled Trials

Zealand University Hospital1 个研究点 分布在 1 个国家目标入组 307 人开始时间: 2021年4月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
307
试验地点
1
主要终点
Duration of recovery

研究概览

简要总结

The study will review data collected in 5 previously completed randomised controlled trials with a new primary outcome: to assess whether administration of the transmuscular quadratus lumborum block has an impact on the time an individual patient stays in the postanaesthesia care unit and how much opioid is consumed during this specified time.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Elective Surgery

排除标准

  • Inability to cooperate
  • Allergy to local anaesthetics or opioids
  • Inability to understand Danish
  • Regular intake of opioids
  • Local infection at site of injection

研究组 & 干预措施

Hemicolectomy, Active treatment

2x30mL 0.375% Ropivacaine administered by way of transmuscular quadratus lumborum block

干预措施: Ropivacaine injection (Drug)

Nephrectomy, Active treatment

2x30mL 0.375% Ropivacaine administered by way of transmuscular quadratus lumborum block

干预措施: Ropivacaine injection (Drug)

Percutaneous nephrolithotomy, Active treatment

1x30mL 0.75% Ropivacaine administered by way of transmuscular quadratus lumborum block

干预措施: Ropivacaine injection (Drug)

Hysterectomy, Active treatment

2x30mL 0.375% Ropivacaine administered by way of transmuscular quadratus lumborum block

干预措施: Ropivacaine injection (Drug)

Elective Caesarean section, Active treatment

2x30mL 0.375% Ropivacaine administered by way of transmuscular quadratus lumborum block

干预措施: Ropivacaine injection (Drug)

结局指标

主要结局

Duration of recovery

时间窗: 0-300 minutes

Minutes from arrival in PACU to completed recovery (arrival until ready for departure)

次要结局

  • Total time spent in recovery(0-300 minutes)
  • Duration of stay at PACU after completed recovery(0-300 minutes)
  • Total opioid consumption in PACU(0-300 minutes)
  • Highest pain score in PACU(0-300 minutes)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验